Evidence map›Paper›PMID 38819528›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2024

Beyond the acute: pain in long COVID survivors at 1.5 years.

Emel Oguz-Akarsu, Gizem Gullu, Erhan Kilic, Yasemin Dinç, Gonul Akdag, Cansu Rehber, Necdet Karli

Abstract read
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emel Oguz-AkarsuDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey. emeloguz@yahoo.com.ORCID http://orcid.org/0000-0002-0465-4218
Gizem GulluDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Erhan KilicDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Yasemin DinçDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Gonul AkdagDepartment of Neurology, Faculty of Medicine, Kutahya Health Sciences University, Kutahya, Turkey.
Cansu RehberDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Necdet KarliDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLong COVID, characterized by persistent symptoms post-acute COVID-19, remains a subject of intense investigation. This study focuses on pain, a common and notable symptom reported by long COVID patients.

methodA cohort of 191 individuals, initially diagnosed with mild-to-moderate COVID-19, was followed up 1.5 years later to assess the frequency, clinical characteristics, and factors associated with pain persistence.

resultsOur study revealed that 31.9% of participants experienced at least one persistent pain symptom after 1.5 years. Headache emerged as the most prevalent symptom (29.8%), followed by myalgia (5.8%) and neuropathic pain (4.2%). Factors such as female gender and the presence of neuropathic pain symptom were identified as predictors of long-term headaches. Myalgia, showed associations with headache, arthralgia, and low ferritin levels. Persistent neuropathic pain symptom (4.2%) was linked to older age, female gender, sore throat, and headache.

conclusionThis study provides insights into the evolution of pain symptoms over time after COVID-19 infection, emphasizing the interconnection between different pain syndromes. This research contributes to understanding the diverse and evolving nature of pain in long COVID survivors, offering valuable insights for targeted interventions and further investigations into the underlying mechanisms of persistent pain.

Indexed as

COVID-19HeadachePost-Acute COVID-19 SyndromeAdultAgedCohort StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedMyalgiaNeuralgiaSARS-CoV-2SurvivorsHeadachelong-COVIDMyalgiaNeuropathic pain symptomPain

Identifiers

PMID38819528
PMCPMC11306299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.